neurokinin B (Human) [5652]
neurokinin B (Human)
| SMILES | CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(N)=O |
| InChIKey | NHXYSAFTNPANFK-HDMCBQFHSA-N |
| Sequence | DMHDFFVGLM |
| HELM | PEPTIDE1{D.M.H.D.F.F.V.G.L.M.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 14 |
| Rotatable bonds | 38 |
| Log P | -1.598 |
| Molecular weight (Da) | 1209.5 |
| Stereochemistry info | unspecified |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
neurokinin B (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0